Molecular Weight Marker Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 0.76 Billion |
| Market Size (2029) | USD 1.40 Billion |
| CAGR (2024 - 2029) | 13.17 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Molecular Weight Marker Market Analysis
The Molecular Weight Marker Market size is estimated at USD 0.76 billion in 2024, and is expected to reach USD 1.40 billion by 2029, growing at a CAGR of 13.17% during the forecast period (2024-2029).
The market growth is expected to be boosted by factors such as increasing investment in R&D and a growing focus on proteomics and genomics technologies research. The increasing research and development investments by major pharmaceutical and biotechnology companies are one of the major factors driving the usage of molecular weight markers. For example, Pfizer invested USD 10,679 million in R&D in FY 2023. Similarly, Biocon Biologics invested a total of INR 11,194 million (USD 134.17 million) in FY 2023 in its research and development activities.
The increasing research on proteomics and genomics is expected to boost market growth. With the increased usage of ladder systems in proteomic and genomic research, the usage of molecular weight markers is also expected to increase during the forecast period. For instance, according to a report published by Creative Proteomics in November 2023, understanding a protein's molecular weight is crucial for researchers to verify its identification and outline its characteristics. This drives the growth of the molecular weight marker market as it underscores the necessity for precise, reliable tools in protein analysis and characterization.
By comparing the experimentally determined molecular weight with the predicted molecular weight derived from the protein sequence, scientists can confirm the protein's identity and validate any post-translational modifications that may have occurred. Additionally, the rising developments of such protein ladders or molecular weight markers are also expected to boost the growth of the market.
Increasing product launches by major players are expected to propel the growth of the market during the forecast period. For instance, in November 2022, Creative Enzymes launched their new line of highly efficient and cost-effective DNA markers and ladders, which quickly gained popularity in the research market.
However, the lack of skilled healthcare professionals and strict government regulations are expected to impede market growth. Overall, the above-mentioned factors, such as increasing investment in R&D and a growing focus on proteomics and genomics technologies research, are expected to drive market growth despite the challenges posed by regulations and a shortage of skilled professionals.
Molecular Weight Marker Market Trends
The RNA Marker Segment is Expected to Show Significant Growth Over the Forecast Period
RNA molecular weight markers are synthetic chains of defined lengths that are used to determine the molecular weight of RNA species. These markers are typically prepared by in vitro transcription of linearized plasmids using RNA polymerases in separate reactions. They are then dissolved in a storage buffer, such as EDTA, and have a shelf life of up to 2 years when stored at -80 °C. Markers are usually stained to make them detectable on gel electrophoresis, with the most commonly used dye being ethidium bromide. RNA markers are commonly used as size standards in northern blotting and RNA gel electrophoresis.
The demand for RNA markers in research, particularly in studies involving denaturing acrylamide gel electrophoresis, underscores the growing importance of molecular weight markers. For instance, according to an article published by PLOS One Journal in August 2022, a study was carried out for both in vitro and in vivo mapping of RNA structure. During this study, denaturing acrylamide gel electrophoresis of the pool of p-labeled cDNAs and the corresponding sequencing RNA ladders were used, highlighting the importance of RNA markers in research.
In addition to their increasing usage in genomic research, major pharmaceutical and biotechnology companies are investing more in research and development activities, which is expected to boost the segment for RNA markers. The government of New South Wales in Australia allocated USD 119 million over 10 years to RNA R&D to support a pipeline of projects for piloting at the facility, as published in December 2022.
Overall, the increasing investment in R&D in genomic research, including cancer genomics, and the growing focus on genomics technologies research are expected to drive the growth of the RNA marker segment.
North America is Expected to Hold a Significant Market Share Over the Forecast Period
The North American market for molecular weight markers is heavily influenced by the presence of numerous large pharmaceutical and biotechnology companies in the United States, as well as the growing burden of various infectious and chronic diseases and the rising investment in research and development (R&D).
In November 2023, the Canadian Cancer Society projected that 247,100 individuals would be diagnosed with cancer in 2024. This anticipated increase in incidence could be attributed to Canada's aging and expanding population. Therefore, the rising prevalence of chronic diseases is expected to result in increased research and development activities, driving the growth of the molecular weight markers market in the region over the forecast period.
In September 2022, the Centers for Disease Control and Prevention (CDC) allocated USD 90 million to the Pathogen Genomics Centers of Excellence (PGCoE) network. The PGCoE network is intended to foster and enhance innovation and technical capacity in pathogen genomics, molecular epidemiology, and bioinformatics to better prevent, control, and respond to microbial threats of public health importance. Such investments in genomics are expected to increase the usage of molecular weight markers during the forecast period.
Major players in the market have been working on novel growth strategies in recent years to gain a higher market share during the forecast period. For instance, in August 2022, Bio-Rad Laboratories, Inc., a well-known manufacturer of molecular weight markers, completed the acquisition of all the outstanding shares of Curiosity Diagnostics Sp. z.o.o. from Scope Fluidics SA. Such advancements in the market are expected to enhance the company's product portfolio and technological capabilities, thereby driving growth in the molecular weight marker market through expanded offerings and increased market reach.
As a result, the aforementioned factors, such as increased investment in research and development and a rising prevalence of chronic and infectious diseases, are expected to drive the growth of the market.
Molecular Weight Marker Industry Overview
The market for molecular weight markers is fragmented, with several major players competing for market share. Several key players are currently concentrating on developing innovative products and advancing their technology to expand their global market reach and increase their market share.
Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, Thermo Fisher Scientific, and VWR International are among the leading companies in this market, holding significant shares.
Molecular Weight Marker Market Leaders
-
Merck KGaA
-
Thermo Fisher Scientific
-
Qiagen
-
Bio-Rad Laboratories
-
Promega Corporation
*Disclaimer: Major Players sorted in no particular order
Molecular Weight Marker Market News
- December 2023: TransGen Biotech Co. Ltd launched its nucleic acid electrophoresis-related equipment to fully establish a powerful combination of equipment and reagents to boost life science research.
- November 2023: TransGen Biotech Co. Ltd launched its western blot vertical electrophoresis and transfer system. Western Blot is an experimental method in molecular biology, biochemistry, and immunogenetics.
Molecular Weight Marker Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Investment on R&D
- 4.2.2 Growing Focus on Proteomics and Genomics Technologies Research
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Healthcare Professionals
- 4.3.2 Strict Government Regulations
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Product
- 5.1.1 DNA Marker
- 5.1.2 Protein Marker
- 5.1.3 RNA Marker
-
5.2 By Application
- 5.2.1 Nucleic Acid Application (PCR, Northern Blotting, Southern Blotting, Molecular Cloning, and Other Nucleic Acid Applications)
- 5.2.2 Proteomics Application (Western Blotting, Gel Extraction, and Other Proteomics Applications)
-
5.3 By Type
- 5.3.1 Prestained Marker
- 5.3.2 Unstained Marker
- 5.3.3 Specialty Marker
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Agilent Technologies Inc.
- 6.1.2 Bio-Rad Laboratories Inc.
- 6.1.3 F Hoffmann-La Roche AG
- 6.1.4 Merck KGaA
- 6.1.5 New England Biolabs
- 6.1.6 Promega Corporation
- 6.1.7 QIAGEN NV
- 6.1.8 Thermo Fisher Scientific Inc.
- 6.1.9 VWR International
- 6.1.10 Takara Bio Inc.
- 6.1.11 HiMedia Laboratories
- 6.1.12 GeneDireX Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityMolecular Weight Marker Industry Segmentation
As per the scope of the report, molecular-weight markers are a set of standards that are used to identify the approximate size of a molecule run on a gel during electrophoresis. Protein, DNA, and RNA molecular weight markers are commercially available.
The molecular weight marker market is segmented by product, application, type, and geography. The product segment is sub-segmented into DNA marker, protein marker, and RNA marker. The application segment is sub-segmented into nucleic acid application and proteomics application. The type segmented is further divided into prestained marker, unstained marker, and specialty marker. The geography segment is further divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD) for all the above segments.
| By Product | DNA Marker | |
| Protein Marker | ||
| RNA Marker | ||
| By Application | Nucleic Acid Application (PCR, Northern Blotting, Southern Blotting, Molecular Cloning, and Other Nucleic Acid Applications) | |
| Proteomics Application (Western Blotting, Gel Extraction, and Other Proteomics Applications) | ||
| By Type | Prestained Marker | |
| Unstained Marker | ||
| Specialty Marker | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Molecular Weight Marker Market Research FAQs
How big is the Molecular Weight Marker Market?
The Molecular Weight Marker Market size is expected to reach USD 0.76 billion in 2024 and grow at a CAGR of 13.17% to reach USD 1.40 billion by 2029.
What is the current Molecular Weight Marker Market size?
In 2024, the Molecular Weight Marker Market size is expected to reach USD 0.76 billion.
Who are the key players in Molecular Weight Marker Market?
Merck KGaA, Thermo Fisher Scientific, Qiagen, Bio-Rad Laboratories and Promega Corporation are the major companies operating in the Molecular Weight Marker Market.
Which is the fastest growing region in Molecular Weight Marker Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Molecular Weight Marker Market?
In 2024, the North America accounts for the largest market share in Molecular Weight Marker Market.
What years does this Molecular Weight Marker Market cover, and what was the market size in 2023?
In 2023, the Molecular Weight Marker Market size was estimated at USD 0.66 billion. The report covers the Molecular Weight Marker Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Molecular Weight Marker Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Molecular Weight Marker Industry Report
Statistics for the 2024 Molecular Weight Marker market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Molecular Weight Marker analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
